Swee Lay Thein, M.D.
National Heart, Lung, and Blood Institute (NHLBI)
14
14
7
N/A
0
23
Research Impact
N/A
Research impact score
0
Total publications
0
Published trial results
0
Total citations
Drug Portfolio
Analytics
Trial Phases
Trial Status
Role Distribution
Activity Timeline
Clinical Trials (14)
Showing 10 of 14 trials
Research Network
Collaboration Network
Research Areas & Affiliations
Therapeutic Areas
Affiliations
Similar Key Opinion Leaders
Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.
Seetha Shankaran, MD
Wayne State University
Shared therapeutic areas:
Worked with same sponsors:
Dale L. Phelps, MD
University of Rochester
Shared therapeutic areas:
Abhik Das, PhD
RTI International
Shared therapeutic areas:
Worked with same sponsors:
Michele C. Walsh, MD MS
Case Western Reserve University, Rainbow Babies and Children's Hospital
Shared therapeutic areas:
Worked with same sponsors:
Murad Alam, MD
Northwestern University
Shared therapeutic areas:
Neil N. Finer, MD
University of California, San Diego
Shared therapeutic areas:
Worked with same sponsors:
Edward F. Donovan, MD
Children's Hospital Medical Center, Cincinnati
Shared therapeutic areas:
Barbara J. Stoll, MD
Emory University
Shared therapeutic areas:
Worked with same sponsors:
Krisa P Van Meurs, MD
Stanford University
Shared therapeutic areas:
Worked with same sponsors:
David K. Stevenson, MD
Stanford University
Shared therapeutic areas:
Publications (0)
No publications found for this investigator.
Clinical Trials (14)
Showing 14 of 14 trials
Escalating Doses of VAS-101 in Subjects With Stable Sickle Cell Disease
Study to Evaluate the Safety and Tolerability of Escalating Doses of Fostamatinib in Subjects With Stable Sickle Cell Disease
Investigating the Mechanistic Effects of Mitapivat in Subjects With Sickle Cell Disease
Exploring Near Infrared Spectroscopy (NIRS) Technologies for Assessment of Muscle Physiology, Tissue Oxygenation, and Blood Flow in Patients With Sickle Cell Disease (SCD)
Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Long-term Mitapivat Dosing in Subjects With Stable Sickle Cell Disease: An Extension of a Phase I Pilot Study of Mitapivat
A Dose-Finding Study of AG-348 in Sickle Cell Disease
Genotype -Phenotype Correlation of PKLR Variants With Pyruvate Kinase, 2,3-Diphosphglycerate and Adenosine Triphosphate Activities in Red Blood Cells of People With Sickle Cell Disease
Phosphodiesterase Type-5 Inhibitor Therapy in Sickle Cell People With Pulmonary Hypertension
Pathophysiology of Acute Pain in Patients With Sickle Cell Disease
Genetics and Pain Severity in Sickle Cell Disease
Secondary Pulmonary Hypertension in Adults With Sickle Cell Anemia
Blood Collection for Research Related to Certain Diseases Involving Blood Vessels
Pulmonary Hypertension in Patients With Sickle Cell Disease in Nigeria
All 14 trials loaded